Novavax, Inc. (NVAX)
| Market Cap | 9.83B |
| Revenue (ttm) | 1.18B |
| Net Income (ttm) | -949.91M |
| Shares Out | 74.12M |
| EPS (ttm) | -13.84 |
| PE Ratio | n/a |
| Forward PE | 2.90 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,068,683 |
| Open | 133.32 |
| Previous Close | 134.56 |
| Day's Range | 130.80 - 135.99 |
| 52-Week Range | 76.59 - 331.68 |
| Beta | 1.59 |
| Analysts | Buy |
| Price Target | 264.20 (+95.2%) |
| Est. Earnings Date | Nov 4, 2021 |
About NVAX
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate...
Financial Performance
In 2020, Novavax's revenue was $475.60 million, an increase of 2,448.48% compared to the previous year's $18.66 million. Losses were -$418.26 million, 215.2% more than in 2019.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for Novavax stock is "Buy." The 12-month stock price forecast is 264.20, which is an increase of 95.20% from the latest price.
News
NOVAVAX INVESTIGATED: The Klein Law Firm Announces an Investigation on Behalf of Novavax, Inc. Investors
New York, New York--(Newsfile Corp. - October 25, 2021) - The Klein Law Firm has begun an investigation into Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) concerning possible violations of f...
Novavax Investor Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...
Novavax is Now a Riskier Play, but Still One to Keep Your Eye On
NVAX stock is even more of a gamble thanks to manufacturing issues, but the next move for the beaten-down shares could still be up. The post Novavax is Now a Riskier Play, but Still One to Keep Your Eye...
The Law Offices of Frank R. Cruz Announces Investigation of Novavax, Inc. (NVAX) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)---- $NVAX #investors--The Law Offices of Frank R. Cruz Announces Investigation of Novavax, Inc. (NVAX) on Behalf of Investors
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages I...
LOS ANGELES, Oct. 25, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novavax, Inc. ("Novavax...
NOVAVAX ALERT: Bragar Eagel & Squire, P.C. Is Investigating Novavax, Inc. on Behalf of Novavax Stockholders and Encou...
NEW YORK--(BUSINESS WIRE)-- #Novavax--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Novavax, Inc. (“Novavax” or the “Company...
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Biotech stocks that fall hard on bad news can rebound in a flash.
Novavax Update
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...
Novavax Is Set to Win on the Increasing Necessity of Booster Shots
NVAX stock has dropped a significant amount recently, but this could be a terrific buying opportunity for savvy long-term investors. The post Novavax Is Set to Win on the Increasing Necessity of Booster...
Why Novavax Fell by 3% Today
Good news for a rival's coronavirus vaccine compounds worries about the company's shot.
NVAX SHAREHOLDERS- Possible Securities Fraud Violations by Novavax, Inc.: The Law Offices of Vincent Wong Investigate
New York, New York--(Newsfile Corp. - October 22, 2021) - The Law Offices of Vincent Wong announce an investigation of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) concerning possible viola...
NOVAVAX INVESTIGATION: Block & Leviton Is Investigating Novavax Inc. For Potential Securities Law Violations; Investo...
Boston, Massachusetts--(Newsfile Corp. - October 22, 2021) - Block & Leviton is investigating Novavax Inc. (NASDAQ: NVAX) for potential securities law violations. Investors who have lost money in their ...
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages...
LOS ANGELES--(BUSINESS WIRE)---- $NVAX #NVAX--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novavax, Inc. (“Nova...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Novavax, Inc. (NVAX) on Behalf of Investors
BENSALEM, Pa.--(BUSINESS WIRE)---- $NVAX #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX) investors concerni...
Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?
Novavax shares plummeted 15% in one trading session this week.
What's the Outlook for Novavax Stock?
Novavax's prospects depend on the company resolving its manufacturing issues.
3 Dirt-Cheap Stocks Wall Street Thinks Will Soar 43% to 80%
Analysts are bullish about these bargains.
Why BioNTech and RedHill Are Soaring This Week, While Novavax Is Sinking
All three have COVID-19 connections.
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages In...
LOS ANGELES--(BUSINESS WIRE)---- $NVAX #NVAX--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc.
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know
Novavax (NVAX) closed the most recent trading day at $138.79, moving +1.41% from the previous trading session.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Novavax, Inc. (NVAX) on ...
LOS ANGELES--(BUSINESS WIRE)---- $NVAX #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf...
NVAX Alert: Berman Tabacco Announces Investigation of Novavax, Inc. for Potential Securities Law Violations
Boston, Massachusetts--(Newsfile Corp. - October 21, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Novavax, Inc. ("Novavax" ...
Novavax Shareholder Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...
Novavax (NVAX) Down on COVID Jab-Manufacturing Problem Reports
Novavax's (NVAX) shares fall on reports of the company's manufacturing problems related to its COVID-19 vaccine candidate.
NVAX ALERT: The Gross Law Firm Investigates Possible Securities Fraud Violations by Novavax, Inc.
New York, New York--(Newsfile Corp. - October 21, 2021) - ATTENTION NVAX INVESTORS:The Gross Law Firm is investigating Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) concerning possible viola...